Douglas Ball, MD
Clinical Genetics (M.D.) · Salt Lake City, UTNPI 1730381625
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Sanofi at 24.2% of the total. Reporting peaked in 2024 at $325 and has fallen 65.9% since, to $111 in 2025.
Across 26 payments — averaging $22.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$140
- Biocryst US Sales Co., LLC$104
- Takeda Pharmaceuticals U.S.A., Inc.$78
- Pharming Healthcare, Inc.$61
- AstraZeneca$58
- LEO Pharma Inc.$43
- plus $95 from 4 others
What the payments were for
- Food & beverage$579100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 5 | $140 |
| Biocryst US Sales Co., LLC | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Pharming Healthcare, Inc. | 3 | $61 |
| AstraZeneca | 3 | $58 |
| LEO Pharma Inc. | 2 | $43 |
| Blueprint Medicines Corporation | 2 | $32 |
| Alkermes, Inc. | 1 | $24 |
| CSL Behring | 1 | $21 |
| Kaleo, Inc. | 1 | $18 |
How this compares
Too few clinical genetics (m.d.) providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical genetics (m.d.) in Salt Lake City
- David ViskochilSalt Lake City$75K
- Lorenzo BottoSalt Lake City$2K
- John CareySalt Lake City$2K
- Vanina TaliercioSalt Lake City$920
- Stacey ColeSalt Lake City$143
- Steven BleylSalt Lake City$42
- Julie LanderSalt Lake City$40
- Ellen ArchSt George$160
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.